GO:0010840 regulation of circadian sleep/wake cycle, wakefulness: Neurobiology, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0010840 describes any process that modulates the rate, frequency, or extent of the wakeful phase of the circadian sleep/wake cycle, where the organism is not asleep.
• Wakefulness is actively generated by arousal systems rather than being a passive default state, and it is coordinated with circadian timing.
• The sleep-wake cycle is regulated by interacting circadian and homeostatic processes, with feedback between brain activity and physiology.
• The sleep-wake cycle influences brain interstitial fluid tau dynamics in mice and CSF tau in humans, linking wakefulness regulation to neurodegeneration research.
• Peripheral clocks, including the intestinal clock, can shape the sleep-wake cycle via metabolic signals such as glutamine homeostasis.
• Melatonin and its receptors are key regulators of circadian sleep-wake timing, and their roles extend beyond traditional views.
Description
The Gene Ontology term GO:0010840, regulation of circadian sleep/wake cycle, wakefulness, refers to any process that modulates the rate, frequency, or extent of the wakeful phase of the circadian sleep/wake cycle, where the wakeful phase is the part of the cycle in which the organism is not asleep. This term captures the regulatory control of wakefulness as an active biological process rather than a simple absence of sleep. Understanding this process is central to chronobiology, sleep medicine, and neuroscience because wakefulness is dynamically generated and timed by interacting circadian and homeostatic systems. The sleep-wake cycle is a fundamental biological rhythm that organizes physiology across the day and night, and its regulation involves feedback between neural activity, circadian clocks, and peripheral signals. Research on this term spans molecular, cellular, circuit, and behavioral levels, and it has direct implications for human health, including sleep disorders, metabolic disease, and neurodegenerative conditions. Because wakefulness is not a passive state, researchers study the specific genes, neurons, and signaling pathways that promote and stabilize it, as well as those that terminate it to allow sleep. This article summarizes the definition, mechanisms, key genes, disease links, and experimental methods relevant to GO:0010840, based on published literature.
regulation of circadian sleep/wake cycle, wakefulness At A Glance
| GO ID | GO:0010840 |
|---|---|
| GO term | regulation of circadian sleep/wake cycle, wakefulness |
| Ontology | biological_process |
| Synonym | none |
| Definition | Any process that modulates the rate, frequency, or extent of the wakeful phase of the circadian sleep/wake cycle. The wakeful phase is the part of the circadian sleep/wake cycle where the organism is not asleep. |
| Major function | Regulation of the timing, duration, and intensity of wakefulness within the circadian sleep/wake cycle |
| Related processes | Circadian rhythm, sleep-wake cycle, arousal, homeostatic sleep regulation |
| Research relevance | Sleep disorders, neurodegeneration, metabolic disease, chronobiology, neuropharmacology |
What Is GO:0010840?
GO:0010840 is a biological process term defined as any process that modulates the rate, frequency, or extent of the wakeful phase of the circadian sleep/wake cycle. The wakeful phase is the portion of the circadian sleep/wake cycle during which the organism is not asleep. In other words, this term covers the regulatory mechanisms that control how much, how often, and how strongly wakefulness occurs within the daily sleep-wake rhythm. It is not the wakefulness state itself, but the modulation of that state.
Why Is regulation of circadian sleep/wake cycle, wakefulness Important in Cell Biology?
GO:0010840 is important because wakefulness regulation affects nearly every aspect of physiology, from brain function and metabolism to immune and endocrine activity. Disruption of the circadian sleep/wake cycle is associated with sleep disorders, cognitive impairment, and increased risk of chronic disease. The sleep-wake cycle also regulates brain interstitial fluid tau in mice and CSF tau in humans, directly linking wakefulness regulation to neurodegenerative disease research. In addition, peripheral clocks such as the intestinal clock can shape the sleep-wake cycle through metabolic signals, highlighting the systemic importance of this process. Melatonin and its receptors are established regulators of circadian sleep-wake timing, and their roles continue to be refined. Studying GO:0010840 therefore provides mechanistic insight into normal physiology and disease, and it supports the development of targeted interventions for sleep and circadian disorders.
• Wakefulness is actively generated by arousal systems, so its regulation is a core neuroscience question.
• The circadian sleep/wake cycle is coordinated by interacting circadian and homeostatic processes.
• Sleep-wake regulation influences brain interstitial fluid tau and CSF tau, linking it to neurodegeneration.
• Disrupted sleep-wake regulation is associated with sleep disorders across the lifespan, including in infants and children.
• Peripheral clocks, including the intestinal clock, can shape the sleep-wake cycle via metabolic signals.
• Melatonin and melatonin receptors are key regulators of circadian sleep-wake timing.
• Sleep-wake neurobiology is a foundation for understanding arousal, vigilance, and consciousness.
• The history of sleep research shows that wakefulness regulation has long been a central biomedical topic.
• Understanding GO:0010840 supports development of therapies for circadian and sleep disorders.
• Sleep-wake regulation is relevant to metabolic health through gut-clock and glutamine-dependent mechanisms.
What Happens During regulation of circadian sleep/wake cycle, wakefulness?
Circadian timing of wakefulness
In simple terms: The body clock sets the daily window when wakefulness is most likely to occur.
The circadian system provides timing signals that determine when wakefulness is promoted and when sleep is favored. In humans, circadian rhythms interact with homeostatic sleep pressure to regulate the sleep-wake cycle across the 24-hour day. The circadian regulation of wakefulness is not simply a passive consequence of clock time; it involves active modulation of arousal systems so that wakefulness occurs at appropriate phases of the cycle. This timing is influenced by both central and peripheral clocks, and disruption of circadian timing can alter the duration and intensity of wakefulness.
Arousal system activation
In simple terms: Wakefulness is switched on by specific brain systems that keep the brain alert.
Wakefulness is actively generated by arousal systems in the brain that promote cortical activation and behavioral alertness. The neurobiology of the sleep-wake cycle includes regulatory feedback between sleep-promoting and wake-promoting circuits. These systems ensure that wakefulness is maintained during the active phase and can be rapidly engaged in response to environmental demands. The activity of these arousal systems is modulated by circadian signals and by homeostatic sleep need, allowing flexible control of wakefulness.
Homeostatic sleep pressure and wakefulness
In simple terms: The longer you stay awake, the stronger the pressure to sleep becomes.
Homeostatic sleep pressure accumulates during wakefulness and dissipates during sleep, and it interacts with circadian timing to regulate the sleep-wake cycle. This homeostatic process modulates the rate and extent of wakefulness by increasing sleep propensity over time. The balance between circadian wake promotion and homeostatic sleep pressure determines the timing and duration of wakefulness episodes. Experimental studies in humans and animal models have characterized this interaction as a core feature of sleep-wake regulation.
Metabolic and peripheral clock inputs
In simple terms: Organs like the gut can send signals that influence how long and how well you stay awake.
Peripheral clocks, including the intestinal clock, can shape the sleep-wake cycle through metabolic signals. Recent work shows that the intestinal clock sustains glutamine homeostasis to influence the sleep-wake cycle, demonstrating that peripheral metabolic rhythms can regulate wakefulness. This indicates that GO:0010840 is not confined to the brain but integrates systemic metabolic information. Such findings expand the regulatory network of wakefulness to include gut-derived signals and nutrient handling.
Melatonergic modulation
In simple terms: Melatonin helps set the timing of sleep and wakefulness.
Melatonin and its receptors are established regulators of circadian sleep-wake timing, and their roles are being re-examined beyond traditional views. Melatonergic signaling can modulate the phase and amplitude of circadian rhythms, thereby influencing when wakefulness occurs. This pathway is an important target for understanding how wakefulness is regulated at the molecular level and for developing chronobiotic interventions. The interaction of melatonin with circadian and homeostatic systems contributes to the overall regulation of the sleep-wake cycle.
Key Genes Involved in GO:0010840 regulation of circadian sleep/wake cycle, wakefulness
The following genes and proteins have been implicated in the regulation of the circadian sleep/wake cycle and wakefulness in published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| Clock | Core circadian clock transcription factor | Central regulator of circadian timing of wakefulness |
| Bmal1 (Arntl) | Core circadian clock transcription factor | Controls circadian rhythms that gate wakefulness |
| Per1 | Circadian clock repressor | Modulates circadian period and sleep-wake timing |
| Per2 | Circadian clock repressor | Linked to circadian regulation of sleep-wake cycles |
| Cry1 | Circadian clock repressor | Regulates circadian timing and wakefulness |
| Cry2 | Circadian clock repressor | Regulates circadian timing and wakefulness |
| Rev-erb alpha (Nr1d1) | Circadian clock component | Modulates circadian output and sleep-wake regulation |
| Ror alpha (Rora) | Circadian clock component | Influences circadian rhythm stability |
| MT1 (Mtnr1a) | Melatonin receptor | Mediates melatonergic effects on sleep-wake timing |
| MT2 (Mtnr1b) | Melatonin receptor | Mediates melatonergic effects on sleep-wake timing |
| AANAT | Melatonin synthesis enzyme | Controls melatonin production and circadian timing |
| HIOMT (ASMT) | Melatonin synthesis enzyme | Controls melatonin production and circadian timing |
| Orexin (Hcrt) | Wake-promoting neuropeptide | Regulates arousal and wakefulness stability |
| MCH | Sleep-promoting neuropeptide | Regulates sleep-wake balance |
| Histamine (Hdc) | Wake-promoting neurotransmitter | Modulates arousal and wakefulness |
| GABA | Inhibitory neurotransmitter | Regulates sleep-promoting circuits |
| Glutamine synthetase (Glul) | Glutamine homeostasis enzyme | Intestinal clock-dependent regulation of sleep-wake cycle |
How Is regulation of circadian sleep/wake cycle, wakefulness Regulated?
The regulation of GO:0010840 involves interactions between circadian clocks, homeostatic sleep pressure, and peripheral metabolic signals. The intestinal clock can regulate the sleep-wake cycle by sustaining glutamine homeostasis, indicating that metabolic pathways can modulate wakefulness. Melatonin and its receptors provide an additional layer of regulation by influencing circadian timing. At the systems level, feedback between sleep-promoting and wake-promoting circuits ensures that wakefulness is appropriately timed and terminated. These regulatory mechanisms are distributed across the brain and periphery, and they integrate environmental and physiological cues to control the wakeful phase of the circadian sleep/wake cycle.
regulation of circadian sleep/wake cycle, wakefulness and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| Clock | Circadian rhythm sleep disorders | Knockout mouse, cell-based circadian reporter |
| Bmal1 (Arntl) | Circadian disruption, metabolic syndrome | Conditional knockout, overexpression |
| Per2 | Advanced sleep phase syndrome | Point mutation knock-in, knockout |
| Mtnr1b (MT2) | Sleep disorders, circadian misalignment | Knockout, receptor agonist studies |
| Glul | Metabolic regulation of sleep-wake cycle | Intestinal-specific knockout, overexpression |
Sleep disorders and circadian rhythm disorders
Disruption of the regulation of the circadian sleep/wake cycle is a hallmark of sleep disorders, including insomnia, circadian rhythm sleep-wake disorders, and sleep disturbances in children. The interaction between circadian and homeostatic systems is central to understanding these conditions, and abnormalities in wakefulness regulation can lead to excessive daytime sleepiness or difficulty maintaining sleep. Research on GO:0010840 provides a framework for identifying molecular targets for therapeutic intervention in sleep and circadian disorders.
Neurodegeneration and tau pathology
The sleep-wake cycle regulates brain interstitial fluid tau in mice and CSF tau in humans, linking wakefulness regulation to neurodegenerative disease. This finding suggests that disruption of the circadian sleep/wake cycle may influence tau dynamics and potentially contribute to neurodegeneration. Studying GO:0010840 in the context of tau pathology could reveal mechanisms by which sleep-wake disturbances affect brain health. This has implications for Alzheimer's disease and other tauopathies, where sleep-wake abnormalities are common.
Metabolic disease and gut clock
The intestinal clock shapes the sleep-wake cycle via sustaining glutamine homeostasis, connecting GO:0010840 to metabolic regulation. Disruption of this gut-clock-dependent pathway may contribute to metabolic disorders and sleep-wake disturbances. This highlights the importance of considering peripheral clocks and metabolic signals in the regulation of wakefulness. Research in this area may identify new targets for treating sleep-wake abnormalities associated with metabolic disease.
Melatonergic system and therapeutic targeting
Melatonin, melatonin receptors, and sleep are moving beyond traditional views, with expanding roles in circadian regulation. Dysregulation of melatonergic signaling can affect the timing and quality of wakefulness, contributing to sleep disorders. Targeting melatonin receptors is a established strategy for modulating circadian sleep-wake timing, and ongoing research continues to refine this approach. Understanding GO:0010840 in the context of melatonergic signaling may inform the development of chronobiotic therapies.
From regulation of circadian sleep/wake cycle, wakefulness-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does a candidate gene regulate wakefulness? | Knockout cell or animal model with sleep-wake monitoring |
| Does a specific mutation alter circadian timing? | Point mutation knock-in model |
| Does a gene variant affect protein function? | Knock-in of disease-associated variant |
| Where is a protein expressed in the brain? | Tagged knock-in with imaging |
| Does overexpression of a gene alter wakefulness? | Overexpression cell or animal model |
| Which genes are required for circadian rhythm? | CRISPR library screening in circadian reporter cells |
How to Study the regulation of circadian sleep/wake cycle, wakefulness Process
| Method | What It Measures | Typical Application |
|---|---|---|
| EEG/EMG | Sleep architecture and wakefulness | Quantifying wakefulness in animal models |
| Locomotor activity monitoring | Circadian activity rhythms | Assessing circadian timing of wakefulness |
| Bioluminescent reporters | Circadian gene expression | High-throughput circadian screening |
| RNA sequencing | Gene expression profiles | Identifying clock-controlled genes |
| Proteomics | Protein abundance and modifications | Studying clock protein dynamics |
| Metabolomics | Metabolite levels | Linking metabolism to sleep-wake regulation |
| CRISPR screening | Gene function in circadian cells | Discovering regulators of wakefulness |
Behavioral sleep-wake monitoring
Electroencephalography (EEG) and electromyography (EMG) are used to record sleep architecture and wakefulness in animal models and humans. These methods allow researchers to quantify the rate, frequency, and extent of wakefulness, which are the parameters modulated in GO:0010840. Sleep scoring based on EEG/EMG is a standard approach for assessing circadian sleep-wake regulation.
Circadian rhythm assays
Circadian rhythms can be measured using locomotor activity monitoring, wheel-running, or bioluminescent reporters in cells and tissues. These assays reveal the timing of wakefulness and its regulation by clock genes. In vitro circadian reporter systems enable high-throughput screening of genes that modulate the wakeful phase.
Molecular profiling of clock genes
RNA sequencing, quantitative PCR, and proteomics can be used to profile the expression of clock genes and wakefulness-related genes across the day-night cycle. These methods help identify molecular correlates of wakefulness regulation and can be applied to knockout or knock-in models. Bioinformatics analysis of circadian transcriptomes is essential for understanding the regulatory networks underlying GO:0010840.
Metabolic and peripheral clock measurements
Metabolic parameters such as glutamine levels and intestinal clock gene expression can be measured to study peripheral regulation of the sleep-wake cycle. These approaches link GO:0010840 to systemic metabolism and gut physiology. Combining metabolic assays with sleep monitoring provides a comprehensive view of wakefulness regulation.
How CRISPR Can Be Used to Study GO:0010840 regulation of circadian sleep/wake cycle, wakefulness
Knockout
CRISPR knockout models are used to delete candidate genes and assess their role in the regulation of the circadian sleep/wake cycle. For example, knocking out clock genes such as Clock or Bmal1 in cells or mice can reveal their requirement for normal wakefulness timing. Knockout studies help establish causality between a gene and the regulation of wakefulness, which is essential for understanding GO:0010840.
Point Mutation
Point mutation knock-in models introduce specific disease-associated or functional variants into endogenous genes. This approach can be used to study how single amino acid changes in clock proteins or melatonin receptors affect wakefulness regulation. Point mutations allow researchers to dissect the precise molecular mechanisms underlying GO:0010840 without confounding effects of complete gene deletion.
Knock-in
Knock-in models can be used to tag endogenous proteins with reporters or epitopes, enabling visualization and biochemical analysis of clock components in vivo. Knock-in of human variants into model organisms can also model human circadian phenotypes. These models are valuable for studying the spatial and temporal dynamics of wakefulness-regulating proteins.
Overexpression
Overexpression models increase the level of a candidate gene to test whether excess protein alters wakefulness or circadian timing. For example, overexpressing a clock gene or a metabolic enzyme such as Glul can reveal gain-of-function effects on the sleep-wake cycle. Overexpression studies complement knockout approaches and help define the regulatory range of genes involved in GO:0010840.
How EDITGENE Supports regulation of circadian sleep/wake cycle, wakefulness Research
Researchers studying regulation of circadian sleep/wake cycle, wakefulness-related genes often need to determine whether a candidate gene is causally involved in the timing, duration, or intensity of wakefulness. Establishing causality requires precise genetic manipulation, and CRISPR-based models provide the necessary tools to test gene function in relevant cell and animal systems. EDITGENE offers a comprehensive suite of services to support such studies, from knockout to overexpression and library screening.
Contact EDITGENE today to design your custom CRISPR model for regulation of circadian sleep/wake cycle, wakefulness research.
Frequently Asked Questions About regulation of circadian sleep/wake cycle, wakefulness
What is GO:0010840?
GO:0010840 is a Gene Ontology biological process term defined as any process that modulates the rate, frequency, or extent of the wakeful phase of the circadian sleep/wake cycle, where the wakeful phase is the part of the cycle in which the organism is not asleep.
What genes are involved in the regulation of circadian sleep/wake cycle, wakefulness?
Key genes include core clock genes such as Clock, Bmal1, Per1, Per2, Cry1, and Cry2, as well as melatonin receptors MT1 and MT2, wake-promoting neuropeptides like orexin, and metabolic regulators such as Glul.
How is wakefulness regulated by the circadian clock?
The circadian clock provides timing signals that determine when wakefulness is promoted, interacting with homeostatic sleep pressure to regulate the sleep-wake cycle.
What is the role of melatonin in the circadian sleep/wake cycle?
Melatonin and its receptors regulate circadian sleep-wake timing, and their roles are being expanded beyond traditional views.
Does the sleep-wake cycle affect tau in the brain?
Yes, the sleep-wake cycle regulates brain interstitial fluid tau in mice and CSF tau in humans, linking wakefulness regulation to neurodegeneration.
Can the gut clock influence wakefulness?
Yes, the intestinal clock shapes the sleep-wake cycle via sustaining glutamine homeostasis.
What research methods are used to study GO:0010840?
Common methods include EEG/EMG sleep monitoring, circadian activity assays, RNA sequencing, proteomics, and CRISPR screening.
How can CRISPR be used to study wakefulness regulation?
CRISPR knockout, point mutation, knock-in, and overexpression models allow researchers to test the causal role of specific genes in the regulation of wakefulness.
What diseases are associated with disrupted regulation of the circadian sleep/wake cycle?
Disrupted regulation is associated with sleep disorders, circadian rhythm disorders, neurodegeneration, and metabolic disease.
Why is GO:0010840 important for researchers?
It provides a standardized framework for studying the regulatory mechanisms that control wakefulness, with implications for sleep medicine, neuroscience, and metabolic health.
Conclusion
GO:0010840, regulation of circadian sleep/wake cycle, wakefulness, is a fundamental biological process that governs the timing, duration, and intensity of wakefulness. It integrates circadian clocks, homeostatic sleep pressure, arousal systems, and peripheral metabolic signals. Research on this term has broad implications for sleep disorders, neurodegeneration, and metabolic disease, and it is supported by a range of experimental methods including CRISPR-based genetic models. Continued investigation of the genes and pathways that regulate wakefulness will advance our understanding of sleep biology and may lead to new therapeutic strategies.
References
- 1. Fuller PM et al.. 2006. Neurobiology of the sleep-wake cycle: sleep architecture, circadian regulation, and regulatory feedback.. J Biol Rhythms 21(6):482-93 PMID: 17107938
- 2. Holth JK et al.. 2019. The sleep-wake cycle regulates brain interstitial fluid tau in mice and CSF tau in humans.. Science 363(6429):880-884 PMID: 30679382
- 3. Bathory E et al.. 2017. Sleep Regulation, Physiology and Development, Sleep Duration and Patterns, and Sleep Hygiene in Infants, Toddlers, and Preschool-Age Children.. Curr Probl Pediatr Adolesc Health Care 47(2):29-42 PMID: 28117135
- 4. Czeisler CA et al.. 2007. Sleep and circadian rhythms in humans.. Cold Spring Harb Symp Quant Biol 72:579-97 PMID: 18419318
- 5. Guo L et al.. 2025. Intestinal clock shapes sleep-wake cycle via sustaining glutamine homeostasis.. Cell Metab 37(12):2423-2437.e6 PMID: 41253158
- 6. Vanini G et al.. 2021. Sleep-Wake Neurobiology.. Adv Exp Med Biol 1297:65-82 PMID: 33537937
- 7. Comai S et al.. 2024. Melatonin, Melatonin Receptors and Sleep: Moving Beyond Traditional Views.. J Pineal Res 76(7):e13011 PMID: 39400423
- 8. Schulz H. 2022. The history of sleep research and sleep medicine in Europe.. J Sleep Res 31(4):e13602 PMID: 35522132
